Cerenome (PSTV) Other Working Capital Changes (2012 - 2026)
Plus Therapeutics (PSTV) posted quarterly Other Working Capital Changes of -$13000.0 for Q1 2026, up 62.86% year-over-year from -$7982.5 in Q1 2025, and down 8.33% quarter-over-quarter from -$12000.0 in Q4 2025.
Cerenome (PSTV) Other Working Capital Changes (2012 - 2026) Analysis & Trends
Plus Therapeutics (PSTV) has reported Other Working Capital Changes for 7 consecutive years, with -$13000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Working Capital Changes rose 62.86% year-over-year to -$13000.0; the TTM figure through Mar 2026 stood at -$44000.0 (up 67.16% YoY), while the FY2025 annual figure was -$66000.0, up 49.23% from the prior year.
- Other Working Capital Changes retreated to -$13000.0 in Q1 2026 per PSTV's latest filing, from -$12000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $3.0 million in Q4 2022 and bottomed at -$2.8 million in Q1 2023.
- Historically, Other Working Capital Changes has averaged -$26375.0 across 5 years, with a median of -$131500.0 in 2022.
- Annual changes were most pronounced in 2024 — Other Working Capital Changes declined 18.52% — and 2025, when it surged 73.53%.
- Plus Therapeutics' Other Working Capital Changes stood at -$28000.0 in 2022, then retreated by 7.14% to -$30000.0 in 2023, then declined by 10.0% to -$33000.0 in 2024, then jumped by 63.64% to -$12000.0 in 2025, then fell by 8.33% to -$13000.0 in 2026.
- Business Quant data shows PSTV's Other Working Capital Changes at -$13000.0 in Q1 2026, -$12000.0 in Q4 2025, and -$9000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.65 Bn | 130.80 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.93 Bn | 77.94 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.84 Bn | 59.66 Bn | 1.37 Bn |
| 4 | Moderna | 57.38 Bn | 52.25 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.94 Bn | 36.84 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.54 Bn | 28.23 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.72 Bn | 9.33 Bn | 668.28 Mn |
| 8 | Insmed | 27.49 Bn | 26.33 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - |
| 10 | Cerenome | 28.07 Mn | 19.48 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -146,000.00 |
| Mar 31, 2026 | -146,000.00 |
| Mar 31, 2026 | -146,000.00 |
| Dec 31, 2025 | 1.40 Mn |
| Dec 31, 2025 | 1.40 Mn |
| Dec 31, 2025 | 1.40 Mn |
| Sep 30, 2025 | -900,000.00 |
| Sep 30, 2025 | -900,000.00 |
| Sep 30, 2025 | -900,000.00 |
| Jun 30, 2025 | 339,000.00 |
| Jun 30, 2025 | 339,000.00 |
| Jun 30, 2025 | 339,000.00 |
| Mar 31, 2025 | -74,000.00 |
| Mar 31, 2025 | -74,000.00 |
| Mar 31, 2025 | -74,000.00 |
| Dec 31, 2024 | 486,000.00 |
| Dec 31, 2024 | 486,000.00 |
| Dec 31, 2024 | 486,000.00 |
| Sep 30, 2024 | -369,000.00 |
| Sep 30, 2024 | -369,000.00 |